Mankind Pharma Sees Q4 Profit Soar 32% on Robust Revenue Growth

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorIshaan Verma|Published at:
Mankind Pharma Sees Q4 Profit Soar 32% on Robust Revenue Growth
Overview

Mankind Pharma announced a strong fourth quarter with net profit rising 31.7% to Rs 554 crore. This growth was powered by an 11.8% increase in revenue to Rs 3,443 crore and improved EBITDA margins of 27%. The company also revealed a Rs 500 crore investment in its subsidiary and a new director appointment.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Mankind Pharma Ltd. reported a strong financial performance for the fourth quarter, with net profit climbing 31.7% to Rs 554 crore from Rs 421 crore in the same period last fiscal year. Consolidated revenue rose 11.8% year-on-year to Rs 3,443 crore, up from Rs 3,079 crore.

Profitability Boosted by Margin Expansion

Operating income, before interest and taxes (EBIT), surged 36.1% to Rs 930 crore from Rs 683 crore. Operating margins widened to 27% in the March-ended quarter, an increase from 22.2% in the prior year's corresponding quarter, indicating enhanced operational efficiency.

Strategic Investments and Board Changes

Beyond the quarterly results, Mankind Pharma's board approved a strategic investment of an additional Rs 500 crore into its subsidiary, Mankind Medicare. Satish Kumar Sharma was also appointed as a Whole-Time Director for five years, strengthening the company's leadership.

Market Reaction

The earnings were announced after market close on Tuesday. Mankind Pharma's stock closed 0.12% lower at Rs 2,492.6 per share, slightly underperforming the NSE Nifty 50 index. Year-to-date, the stock has gained 13.48%, though it has dipped 2.79% over the past 12 months.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.